Skip to main content
Log in

The Stability and Degradation Pathway of Recombinant Human Parathyroid Hormone: Deamidation of Asparaginyl Residue and Peptide Bond Cleavage at Aspartyl and Asparaginyl Residues

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The stability of recombinant human parathyroid hormone (rhPTH) was examined under acidic to alkaline conditions; its degradation pathways were elucidated from resultant products.

Methods. Degradation assay was performed in the pH range 2 to 10 at 40, 50 and 60°C. The approximate molecular mass and pI values of the degradation products were estimated by electrophoresis. FAB-MS peptide mapping and amino acid composition analysis were used to determine these structures. The amount of each respective product was determined by HPLC.

Results. At pH2, eight degradation products were found: l-30rhPTH, l-74rhPTH, l-71rhPTH, l-56rhPTH, l-45rhPTH, 46-84rhPTH, 31-84rhPTH and Asp76-rhPTH; these were mainly as a consequence of peptide bond cleavage of the amide bond of Asp. At pH9, five products were found: isoAsp16-rhPTH, Aspl6-rhPTH, Asp57-rhPTH, Asp76-rhPTH, 17-84rhPTH; the main degradation pathway was deamidation of Asn via a cyclic imide intermediate. Degradation products resulting from cleavage at Asp were increased in proportion to the extent that pH was lowered below 5. As pH was increased above 5, so were products resulting from deamidation of Asn. Correspondingly, levels of intact rhPTH were at a peak at pH5.

Conclusions. Degradation of rhPTH under acidic conditions predominantly occurs by cleavage at Asp, whereas, above pH5, deamidation of Asn is the more prominent. rhPTH is most stable at pH5.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. G. N. Hendy, H. M. Kronenberg, J. T. Potts, Jr., and A. Rich. Proc. Natl. Acad. Sci. USA 78:7365–7369 (1981).

    Google Scholar 

  2. J. T. Potts, Jr., H. M. Kronenberg, and M. Rosenblatt. Adv. Protein Chem. 35:323–396 (1982).

    Google Scholar 

  3. L. Mosekilde, C. H. Søgaard, C. C. Danielsen, O. Tørring, and M. H. L. Nilsson. Endocrinology 129:421–428 (1991).

    Google Scholar 

  4. T. J. Gardella, D. Rubin, A. B. A. Samra, H. T. Keutmann, J. T. Potts Jr., H. M. Kronenberg, and S. R. Nussbaum. J. Biol. Chem. 265:15854–15859 (1990).

    Google Scholar 

  5. Y. Nabuchi, E. Fujiwara, K. Ueno, H. Kuboniwa, Y. Asoh, and H. Ushio. Pharm. Res. 12:2049–2052 (1995).

    Google Scholar 

  6. A. L. Frelinger, III and J. E. Zull. J. Biol. Chem. 259:5507–5513 (1984).

    Google Scholar 

  7. Z. Shahrokh, G. Eberlein, D. Buckley, M. V. Paranandi, D. W. Aswad, P. Stratton, R. Mischak, and Y. J. Wang. Pharm. Res. 11:936–944 (1994).

    Google Scholar 

  8. K. Patel and R. T. Borchardt. Pharm. Res. 7:703–711 (1990).

    Google Scholar 

  9. R. C. Stephenson and S. Clarke. J. Biol. Chem. 264:6164–6170 (1989).

    Google Scholar 

  10. K. Patel and T. Borchardt. Pharm. Res. 7:787–793 (1990).

    Google Scholar 

  11. T. Geiger and S. Clarke. J. Biol. Chem. 262:785–794 (1987).

    Google Scholar 

  12. R. T.-Cross and V. Schirch. J. Biol. Chem. 266:22549–22556 (1991).

    Google Scholar 

  13. C. E. M. Voorter, W. A. de Haard-Hoekman, P. J. M van den Oetelaar, H. Bloemendal, and W. W. de Jong. J. Biol. Chem. 263:19020–19023 (1988).

    Google Scholar 

  14. E. E. Haley, B. J. Corcoran, F. E. Dorer, and D. L. Buchanan. Biochemistry 5:3229–3235 (1966).

    Google Scholar 

  15. A. B. Robinson. Proc. Natl. Acad. Sci. USA 71:885–888 (1974).

    Google Scholar 

  16. A. B. Robinson and C. J. Rudd. Current Top. Cell. Regul. 8:247–295 (1974).

    Google Scholar 

  17. D. Piszkiewicz, M. Landon, and E. L. Smith. Biochem. Biophys. Res. Commun. 40:1173–1178 (1970).

    Google Scholar 

  18. Y. Nabuchi, H. Kuboniwa, H. Takasu, Y Asoh, and H. Ushio. Rapid Commun. Mass Spectrom. 9:257–260 (1995).

    Google Scholar 

  19. V. Wary, T. Federau, W. Gronwald, H. Mayer, D. Schomburg, W. Tegge, and E. Wingender. Biochemistry 33:1684–1693 (1994).

    Google Scholar 

  20. W. Gronwald, D. Schomburg, V. M. P. Harder, H. Mayer, J. Paulsen, E. Wingender, and V. Wary. Biol. Chem. Hoppe-Seyler 377:175–186 (1996).

    Google Scholar 

  21. C. Oliyai and R. T. Borchardt. Pharm. Res. 10:95–102 (1993).

    Google Scholar 

  22. M. Landon. Methods Enzymol. 47:145–149 (1977).

    Google Scholar 

  23. K. Patel and R. T. Borchardt. Pharm. Res. 7:787–793 (1990).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nabuchi, Y., Fujiwara, E., Kuboniwa, H. et al. The Stability and Degradation Pathway of Recombinant Human Parathyroid Hormone: Deamidation of Asparaginyl Residue and Peptide Bond Cleavage at Aspartyl and Asparaginyl Residues. Pharm Res 14, 1685–1690 (1997). https://doi.org/10.1023/A:1012115426306

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012115426306

Navigation